SAULNIER; Mark G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for SAULNIER; Mark G..The latest application filed is for "4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication".
Company Profile
6.27.26
- SAULNIER; Mark G. - Wallingford CT
- Saulnier; Mark G. - Higganum CT
- Saulnier; Mark G. - Newington CT
- Saulnier; Mark G. - Higgannum CT
- Saulnier; Mark G. - Middletown CT
Patent Activity
| Patent | Date |
|---|---|
| 4-oxo-3,4-dihydroquinazoline Compounds As Inhibitors Of Human Immunodeficiency Virus Replication App 20210024503 - BELEMA; Makonen ; et al. | 2021-01-28 |
| Hepatitis C virus inhibitors Grant 10,617,675 - Frennesson , et al. | 2020-04-14 |
| 1,3-dihydroxy-phenyl derivatives useful as immunomodulators Grant 10,590,105 - Yeung , et al. | 2020-03-17 |
| Pyridin-3-yl Acetic Acid Derivatives As Inhibitors Of Human Immunodeficiency Virus Replication App 20200055839 - BELEMA; Makonen ; et al. | 2020-02-20 |
| Pyridin-3-yl Acetic Acid Derivatives As Inhibitors Of Human Immunodeficiency Virus Replication App 20200016136 - BOWSHER; Michael S. ; et al. | 2020-01-16 |
| 1,3-dihydroxy-phenyl Derivatives Useful As Immunomodulators App 20190185450 - YEUNG; Kap-Sun ; et al. | 2019-06-20 |
| Compounds useful as immunomodulators Grant 10,144,706 - Yeung , et al. De | 2018-12-04 |
| Hepatitis C Virus Inhibitors App 20180221342 - Frennesson; David B. ; et al. | 2018-08-09 |
| Compounds Useful As Immunomodulators App 20180057455 - YEUNG; KAP-SUN ; et al. | 2018-03-01 |
| Combinations comprising biphenyl derivatives for use in the treatment of HCV Grant 9,775,831 - Saulnier , et al. October 3, 2 | 2017-10-03 |
| Combinations Comprising Biphenyl Derivatives For Use In The Treatment Of Hcv App 20160166545 - Saulnier; Mark G. ; et al. | 2016-06-16 |
| Substituted azaindazole compounds Grant 9,266,880 - Austin , et al. February 23, 2 | 2016-02-23 |
| Substituted 1,5-benzodiazepinones compounds Grant 9,187,434 - Gill , et al. November 17, 2 | 2015-11-17 |
| Macrocycles and macrocycle stabilized peptides Grant 9,169,295 - Saulnier , et al. October 27, 2 | 2015-10-27 |
| Substituted 1,5-benzodiazepinones Compounds App 20150274679 - Gill; Patrice ; et al. | 2015-10-01 |
| Fluoroalkyl And Fluorocycloalkyl 1,4-benzodiazepinone Compounds App 20150231152 - Zhao; Yufen ; et al. | 2015-08-20 |
| Azaindazole compounds Grant 8,673,922 - Velaparthi , et al. March 18, 2 | 2014-03-18 |
| Pyrrolotriazine kinase inhibitors Grant 8,592,579 - Wittman , et al. November 26, 2 | 2013-11-26 |
| Macrocycles And Macrocycle Stabilized Peptides App 20130281657 - Saulnier; Mark G. ; et al. | 2013-10-24 |
| Substituted Azaindazole Compounds App 20130231354 - Austin; Joel F. ; et al. | 2013-09-05 |
| Azaindazole Compounds App 20130184254 - Velaparthi; Upender ; et al. | 2013-07-18 |
| Pyrrolotriazine kinase inhibitors Grant 8,445,676 - Purandare , et al. May 21, 2 | 2013-05-21 |
| Pyrrolotriazine Kinase Inhibitors App 20120302747 - Wittman; Mark D. ; et al. | 2012-11-29 |
| Pyrrolotriazine Kinase Inhibitors App 20110294816 - Purandare; Ashok Vinayak ; et al. | 2011-12-01 |
| Pyrrolotriazine Kinase Inhibitors App 20110124623 - Wittman; Mark D. ; et al. | 2011-05-26 |
| Pyrrolotriazine kinase inhibitors Grant 7,879,855 - Wittman , et al. February 1, 2 | 2011-02-01 |
| Pyrrolotriazine Kinase Inhibitors App 20090239838 - Wittman; Mark D. ; et al. | 2009-09-24 |
| Pyrrolotriazine kinase inhibitors Grant 7,534,792 - Wittman , et al. May 19, 2 | 2009-05-19 |
| Pyrrolotriazine Kinase Inhibitors App 20080009497 - Wittman; Mark D. ; et al. | 2008-01-10 |
| Tyrosine kinase inhibitors Grant 7,223,757 - Wittman , et al. May 29, 2 | 2007-05-29 |
| Tyrosine kinase inhibitors Grant 7,081,454 - Wittman , et al. July 25, 2 | 2006-07-25 |
| Novel tyrosine kinase inhibitors App 20060079518 - Wittman; Mark D. ; et al. | 2006-04-13 |
| Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles Grant 6,855,698 - Ruediger , et al. February 15, 2 | 2005-02-15 |
| Novel tyrosine kinase inhibitors App 20040044203 - Wittman, Mark D. ; et al. | 2004-03-04 |
| Anhydro sugar derivatives of indolocarbazoles Grant 6,686,385 - Saulnier , et al. February 3, 2 | 2004-02-03 |
| Topoisomerase inhibitors Grant 6,677,450 - Saulnier , et al. January 13, 2 | 2004-01-13 |
| Anhydro Sugar Derivatives Of Indolocarbazoles App 20030220387 - Saulnier, Mark G. ; et al. | 2003-11-27 |
| Anhydro sugar derivatives of indolocarbazoles Grant 6,610,727 - Saulnier , et al. August 26, 2 | 2003-08-26 |
| Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles App 20030083271 - Ruediger, Edward H. ; et al. | 2003-05-01 |
| Anhydro sugar derivatives of indolocarbazoles App 20020111375 - Saulnier, Mark G. ; et al. | 2002-08-15 |
| Topoisomerase inhibitors App 20020107237 - Saulnier, Mark G. ; et al. | 2002-08-08 |
| Epipodophyllotoxin glucoside 4'-phosphate derivatives Grant RE35,524 - Saulnier , et al. June 3, 1 | 1997-06-03 |
| Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells Grant 4,975,278 - Senter , et al. December 4, 1 | 1990-12-04 |
| Dimeric epipodophyllotoxin glucoside derivatives Grant 4,965,348 - Saulnier , et al. October 23, 1 | 1990-10-23 |
| 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives Grant 4,874,851 - Vyas , et al. October 17, 1 | 1989-10-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 